Skip to Main Content

Not a peep.

The jury in the federal trial of five former drug company executives who allegedly bribed doctors to prescribe an opioid painkiller finished its 11th day of deliberations Thursday and still had not reached a verdict. The jury has yet to even send a note to the judge to ask a question, which is unusual for a trial that has gone on for three months.


Jurors are weighing whether the founder of Arizona-based Insys Therapeutics and four other former company executives participated in a racketeering conspiracy. The five allegedly bribed medical practitioners to prescribe a powerful fentanyl product to patients who shouldn’t have gotten it.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!